LINC02709

Across TCGA pan-cancer cohorts, LINC02709 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated LINC02709 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02709 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02709 expression acts as an unfavorable survival marker, although some lineages such as READ and ACC show a favorable association.

BLCA, LIHC, and READ are the cancer types where LINC02709 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	All	0.255	0.412	<.001	130	view →
LIHC	DFS	Median	All	0.460	0.618	<.001	90	view →
READ	DFS	Median	All	0.904	0.507	<.001	62	view →
LGG	OS	Median	All	0.708	0.901	<.001	52	view →
KIRP	DFS	Tertile	All	0.836	0.961	<.001	43	view →
KICH	OS	Median	II,III,IV	0.605	0.963	.001	40	view →
LAML	DFS	Tertile	All	0.260	0.685	.005	30	view →
LUAD	DFS	Median	All	0.608	0.719	.001	28	view →
ACC	OS	Quartile	II,III,IV	0.844	0.363	.002	27	view →
THCA	DFS	Tertile	IV	0.478	0.861	.017	21	view →
ESCA	OS	Quartile	III,IV	0.420	0.750	.003	20	view →
DLBC	DFS	Tertile	All	1.000	0.502	.009	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

LINC02709–BLCA (DFS)

Open the BLCA breakdown →